Skip to main content
. 2020 Mar 12;43(3):431–444. doi: 10.1007/s13402-020-00497-6

Fig. 4.

Fig. 4

JQ1 effects the expression of CSC markers in an in vivo pre-clinical model. a. MYC, ABCG2, ITGA6, EPCAM, SOX9, EZH2, GJA1, FSTL1 and SOX2 mRNA levels in JQ1-treated tumours compared to vehicle-treated tumours. b. CD44, CD24, ALDH1A1, KLF4 and RUNX2 mRNA level changes observed upon JQ1 exposure. The qRT-PCR conditions are described in material and methods. Student t-test: * p < 0,05, ** p < 0,01 and *** p < 0,001